The estimated Net Worth of Harry F Sr Connick is at least $94.1 Tisíc dollars as of 2 March 2016. Mr. Connick owns over 700 units of Psychemedics stock worth over $94,099 and over the last 21 years he sold PMD stock worth over $0. In addition, he makes $0 as Independent Director at Psychemedics.
Sign up
Mr. Connick PMD stock SEC Form 4 insiders trading
Harry has made over 7 trades of the Psychemedics stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 700 units of PMD stock worth $8,981 on 2 March 2016.
The largest trade he's ever made was exercising 6,438 units of Psychemedics stock on 3 September 2013 worth over $52,663. On average, Harry trades about 858 units every 36 days since 2003. As of 2 March 2016 he still owns at least 41,362 units of Psychemedics stock.
You can see the complete history of Mr. Connick stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Harry Connick biography
Harry F. Connick Sr. serves as Independent Director of the Company. He has served as District Attorney for Orleans Parish (New Orleans, LA) from 1974 to 2003. In 2002 Mr. Connick received from Drug Czar, John P. Walters, the Director’s Award for Distinguished Service, in recognition of exemplary accomplishment and distinguished service in the fight against illegal drugs. As a result of these and other professional experiences, Mr. Connick possesses particular knowledge and experience in law enforcement and the effects of drugs of abuse and their effect on society that strengthen the Board’s collective qualifications, skills and experience. Mr. Connick has been a director of the Company since 2003.
How old is Harry Connick?
Harry Connick is 94, he's been the Independent Director of Psychemedics since 2003. There are no older and 10 younger executives at Psychemedics.
What's Harry Connick's mailing address?
Harry's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 289 GREAT ROAD, SUITE 200, ACTON, MA, 01720.
Insiders trading at Psychemedics
Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen a Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.
What does Psychemedics do?
psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics' clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.
What does Psychemedics's logo look like?
Complete history of Mr. Connick stock trades at Psychemedics
Psychemedics executives and stock owners
Psychemedics executives and other stock owners filed with the SEC include:
-
Raymond Kubacki,
Chairman of the Board, President, Chief Executive Officer -
Raymond C. Kubacki,
Chairman, CEO & Pres -
Charles Doucot,
Executive Vice President -
Michael Schaffer,
Vice President - Laboratory Operations -
Charles M. Doucot IV,
Exec. VP -
Dr. Michael I. Schaffer Ph.D.,
VP of Laboratory Operations -
A. Clinton Allen,
Independent Director -
Fred Weinert,
Independent Director -
Walter Tomenson,
Independent Director -
Harry Connick,
Independent Director -
Patrick J. Kinney Jr.,
Sec. -
Sarah Ashby,
VP & Gen. Counsel -
Andrew Limbek,
VP of Fin. & Controller -
Annette Baumgartner,
Founder -
Dr. Werner A. Baumgartner Ph.D.,
Founder -
Peter Kamin,
Director -
Neil Lerner,
VP - Finance -
James V. Dyke,
Vice President - Sales -
Michael Weisenhoff,
-
Raymond J Ruddy,
Vice President/Controller -
Jonathan D Compton,
Vice President - Marketing -
William R Thistle,
Sr. VP and Gen. Counsel -
Peter C Monson,
VP, Treas., CFO & Asst. Sec. -
Jennifer Chmieleski,
Vice President, Controller -
Richard T Christoph,
10% owner -
William Dausey,
Vice President of Sales -
Robyn C Davis,
Director -
Andrew Reynolds,
Director -
Shannon Shoemaker,
Chief Revenue Officer -
Darius G Nevin,
Director -
Brian Hullinger,
President & CEO -
Daniella Mehalik,
Vice President - Finance